Heart disease and chronic kidney disease can accelerate one another, but new guidelines say simple screening and early treatment could substantially reduce the risks. Blood and urine tests, combined with proven heart and kidney therapies, may help catch problems sooner and prevent serious complications.
New Guidelines for Screening and Treatment of Heart and Kidney Diseases
New guidelines suggest that heart disease and chronic kidney disease can exacerbate each other, but early screening and treatment can significantly lower risks. The article highlights the importance of blood and urine tests alongside established therapies. This is relevant for Iran as it addresses public health challenges that could impact healthcare resources and policies.
👥 Key Players
📰 What Happened
New guidelines have been released that emphasize the importance of screening and early treatment for heart and kidney diseases, which can worsen each other. These guidelines advocate for using blood and urine tests to identify issues early on.
- Heart disease and chronic kidney disease can exacerbate each other.
- Early screening and treatment can significantly reduce health risks.
💡 Why It Matters
📚 Background
Heart disease and kidney disease are leading health issues in Iran, contributing to high morbidity rates. Effective management of these conditions is essential for improving overall public health.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%